HopeStage
Back to all studies
Active Not RecruitingNCT04754061

Psilocybin microdosing for distress in advanced illness

About this titleRead the official source — NCT04754061
Medication studyAges 18+CanadaAnxiety
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Ottawa and 1 more locationSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 8, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
20
Sponsor
Ottawa Hospital Research Institute
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Canada
Age range
Over 18 Years
Official registry ID
NCT04754061
Official title
Show the full official title

PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial

Recruitment & locations

Not recruiting

Ottawa

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ottawa Hospital Research Institute, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies